This inventor holds 1 USPTO granted patent. Top assignee: Avigen, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations by Stephen Mejza in Recombinant Adeno-Associated Virus Production
Introduction
Stephen Mejza is an accomplished inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant adeno-associated viruses (rAAV). His work has implications for gene therapy and other medical applications.
Latest Patents
Stephen Mejza holds a patent for "Compositions and methods for producing recombinant adeno-associated virus." This invention provides compositions and methods for producing rAAV virions in large amounts or high titers. Additionally, it includes methods for producing stably transformed host cells capable of producing rAAV virions. He has 1 patent to his name.
Career Highlights
Stephen Mejza is associated with Avigen, Inc., a company known for its innovative approaches in gene therapy and biotechnology. His role at Avigen has allowed him to further develop his ideas and contribute to advancements in the field.
Conclusion
Stephen Mejza's work in the production of recombinant adeno-associated viruses showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in gene therapy and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile